Company

MediciNova, Inc.

MediciNova develops small-molecule therapeutics for diseases with unmet medical needs.

About

Founded in 2000, MediciNova develops small-molecule therapeutics for diseases with unmet medical needs, focusing on neurology, respiratory, and liver conditions. Its portfolio includes MN-001, MN-166, and MN-221. The company is based in California, US. In January 2021, it raised USD 20 million in PIPE funding led by 3D Investment Partners.

3Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in